エディションの選択
国
重点項目
病状
組織の種類
ステークホルダー
品質
ドイツ (2)
Advocacy (policy advocacy, lobbying)
Across all conditions/Other (1)
Pharmaceutical, Biotech, Medical Device Company (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Capacity and capabilities for engagement
Health Technology Assessment (HTA) activities